Ignite Creation Date:
2024-05-06 @ 2:54 AM
Last Modification Date:
2024-10-26 @ 11:25 AM
Study NCT ID:
NCT02150967
Status:
TERMINATED
Last Update Posted:
2023-07-03
First Post:
2014-05-12
Brief Title:
A Phase II Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Sponsor:
QED Therapeutics Inc
Organization:
QED Therapeutics Inc
Organization Data
Organization:
QED Therapeutics Inc
Class:
INDUSTRY
Study ID:
CBGJ398X2204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
QED Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Helsinn Healthcare SA | INDUSTRY |